Colgate-Palmolive upgraded at Morgan Stanley As previously reported, Morgan Stanley upgraded Colgate-Palmolive to Overweight from Equal Weight. The analyst upgraded shares based on relative valuation and expectations organic sales growth will be better than expected given a robust innovation pipeline, a rebound in the pet segment, advertising increases, and easing comps. Price target is $68.
News For CL From The Last 14 Days
Check below for free stories on CL the last two weeks.